Next, we tested whether compound loss of Dmpk, Six5, Mbnl1 and Dmwd could give rise to a mouse model recapitulating the most of the symptoms in DM1 patients and the more severe CDM manifestations. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.